Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Legionellosis after hematopoietic stem cell transplantation

Abstract

Limited data are available on legionellosis after hematopoietic stem cell transplant (HSCT). The aim of this study was to report the cases of legionellosis and to identify predictors of legionellosis, legionellosis-associated death, and non-relapse mortality (NRM). All cases of post-HSCT legionellosis from the EBMT registry were included and matched with controls in a 3:1 ratio for the analyses of risk factors. In the years 1995–2016, 80 cases from 52 centers in 14 countries were identified (mainly from France, Italy, and Spain). Median time from HSCT to legionellosis was 203 days (range, 0–4099); 19 (23.8%) patients developed early legionellosis (within-day +30 post-HSCT). Patients were mainly male (70%), after allogeneic HSCT (70%), with acute leukemia (27.5%), lymphoma (23.8%), or multiple myeloma (21.3%), and the median age of 46.6 (range, 7.2–68.2). Predictors of legionellosis were allogeneic HSCT (OR = 2.27, 95%CI:1.08–4.80, p = 0.03) and recent other infection (OR = 2.96, 95%CI:1.34–6.52, p = 0.007). Twenty-seven (33.8%) patients died due to legionellosis (44% after early legionellosis), NRM was 50%. Predictors of NRM were female sex (HR = 2.19, 95%CI:1.13–4.23, p = 0.02), early legionellosis (HR = 2.24, 95%CI:1.13–4.46, p = 0.02), and south-eastern geographical region (HR = 2.16, 95%CI:1.05–4.44, p = 0.036). In conclusion, legionellosis is a rare complication after HSCT, mainly allogeneic, occurring frequently within 30 days after HSCT and associated with high mortality.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Timing of legionellosis after HSCT.
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Fraser DW, Tsai TR, Orenstein W, Parkin WE, Beecham HJ, Sharrar RG, et al. Legionnaires’ disease: description of an epidemic of pneumonia. N Engl J Med. 1977;297:1189–97.

    Article  CAS  Google Scholar 

  2. Fields BS, Benson RF, Besser RE. Legionella and Legionnaires’ disease: 25 years of investigation. Clin Microbiol Rev. 2002;15:506–26.

    Article  Google Scholar 

  3. European Centre for Disease Prevention and Control. Legionnaires’ disease. In ECDC. Annual epidemiological report for 2016. Stockholm: ECDC 2018.

  4. Horwitz MA. Cell-mediated immunity in Legionnaires’ disease. J Clin Investig. 1983;71:1686–97.

    Article  CAS  Google Scholar 

  5. Lanternier F, Ader F, Pilmis B, Catherinot E, Jarraud S, Lortholary O. Legionnaire’s disease in compromised hosts. Infect Dis Clin North Am. 2017;31:123–35.

    Article  Google Scholar 

  6. Chow JW, Yu VL. Legionella: a major opportunistic pathogen in transplant recipients. Semin Respir Infect. 1998;13:132–9.

    CAS  PubMed  Google Scholar 

  7. Harrington RD, Woolfrey AE, Bowden R, McDowell MG, Hackman RC. Legionellosis in a bone marrow transplant center. Bone Marrow Transpl. 1996;18:361–8.

    CAS  Google Scholar 

  8. Kool JL, Fiore AE, Kioski CM, Brown EW, Benson RF, Pruckler JM, et al. More than 10 years of unrecognized nosocomial transmission of legionnaires’ disease among transplant patients. Infect Control Hosp Epidemiol. 1998;19:898–904.

    Article  CAS  Google Scholar 

  9. Sivagnanam S, Pergam SA. Legionellosis in transplantation. Curr Infect Dis Rep. 2016;18:9.

    Article  Google Scholar 

  10. del Castillo M, Lucca A, Plodkowski A, Huang YT, Kaplan J, Gilhuley K, et al. Atypical presentation of Legionella pneumonia among patients with underlying cancer: a fifteen-year review. J Infect. 2016;72:45–51.

    Article  Google Scholar 

  11. Han XY, Ihegword A, Evans SE, Zhang J, Li L, Cao H, et al. Microbiological and clinical studies of legionellosis in 33 patients with cancer. J Clin Microbiol. 2015;53:2180–7.

    Article  Google Scholar 

  12. Styczynski J, Tridello G, Koster L, Iacobelli S, van Biezen A, van der Werf S, et al. Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors. Bone Marrow Transpl. 2020;55:126–36.

    Article  Google Scholar 

  13. Cunha BA, Burillo A, Bouza E. Legionnaires’ disease. Lancet. 2016;387:376–85.

    Article  Google Scholar 

  14. Lee JV, Joseph C. Guidelines for investigating single cases of Legionnaires’ disease. Commun Dis Public Health. 2002;5:157–62.

    CAS  PubMed  Google Scholar 

  15. Gudiol C, Garcia-Vidal C, Fernandez-Sabe N, Verdaguer R, Llado L, Roca J, et al. Clinical features and outcomes of Legionnaires’ disease in solid organ transplant recipients. Transpl Infect Dis. 2009;11:78–82.

    Article  CAS  Google Scholar 

  16. Bangsborg JM, Uldum S, Jensen JS, Bruun BG. Nosocomial legionellosis in three heart-lung transplant patients: case reports and environmental observations. Eur J Clin Microbiol Infect Dis. 1995;14:99–104.

    Article  CAS  Google Scholar 

  17. Johnson JT, Yu VL, Wagner RL, Best MG. Nosocomial Legionella pneumonia in a population of head and neck cancer patients. Laryngoscope 1985;95:1468–71.

    Article  CAS  Google Scholar 

  18. Cervia JS, Farber B, Armellino D, Klocke J, Bayer RL, McAlister M, et al. Point-of-use water filtration reduces healthcare-associated infections in bone marrow transplant recipients. Transpl Infect Dis. 2010;12:238–41.

    Article  CAS  Google Scholar 

  19. Yokoe D, Casper C, Dubberke E, Lee G, Munoz P, Palmore T, et al. Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated. Bone Marrow Transpl. 2009;44:495–507.

    Article  CAS  Google Scholar 

  20. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recommend Rep. 2000;49(Rr-10):1-125, ce1-7.

  21. World Health Organization. Legionella and the prevention of legionellosis. Geneva: World Health Organization; 2007.

  22. Guidelines for prevention of nosocomial pneumonia. Centers for disease control and prevention. MMWR Recommend Rep. 1997;46:1–79.

    Google Scholar 

  23. Beauté J, Robesyn E, de Jong B. Legionnaires’ disease in Europe: all quiet on the eastern front?. Eur Respir J. 2013;42:1454–8.

    Article  Google Scholar 

  24. Prodinger WM, Bonatti H, Allerberger F, Wewalka G, Harrison TG, Aichberger C, et al. Legionella pneumonia in transplant recipients: a cluster of cases of eight years’ duration. J Hosp Infect. 1994;26:191–202.

    Article  CAS  Google Scholar 

  25. Oren I, Zuckerman T, Avivi I, Finkelstein R, Yigla M, Rowe JM. Nosocomial outbreak of Legionella pneumophila serogroup 3 pneumonia in a new bone marrow transplant unit: evaluation, treatment and control. Bone Marrow Transpl. 2002;30:175–9.

    Article  CAS  Google Scholar 

  26. Lanternier F, Tubach F, Ravaud P, Salmon D, Dellamonica P, Bretagne S, et al. Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study. Chest 2013;144:990–8.

    Article  Google Scholar 

  27. Bodro M, Carratala J, Paterson DL. Legionellosis and biologic therapies. Respir Med. 2014;108:1223–8.

    Article  CAS  Google Scholar 

  28. Tubach F, Ravaud P, Salmon-Ceron D, Petitpain N, Brocq O, Grados F, et al. Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists. Clin Infect Dis. 2006;43:e95–100.

    Article  CAS  Google Scholar 

  29. Nunnink JC, Gallagher JG, Yates JW. Legionnaires’ disease in patients with cancer. Med Pediatr Oncol. 1986;14:81–5.

    Article  CAS  Google Scholar 

  30. Jacobson KL, Miceli MH, Tarrand JJ, Kontoyiannis DP. Legionella pneumonia in cancer patients. Medicine 2008;87:152–9.

    Article  Google Scholar 

  31. Mykietiuk A, Carratala J, Fernandez-Sabe N, Dorca J, Verdaguer R, Manresa F, et al. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clin Infect Dis. 2005;40:794–9.

    Article  CAS  Google Scholar 

  32. Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, et al. Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years. Medicine 2013;92:51–60.

    Article  Google Scholar 

  33. Benin AL, Benson RF, Besser RE. Trends in legionnaires disease, 1980–1998: declining mortality and new patterns of diagnosis. Clin Infect Dis. 2002;35:1039–46.

    Article  Google Scholar 

  34. Cunha BA, Klein NC, Strollo S, Syed U, Mickail N, Laguerre M. Legionnaires’ disease mimicking swine influenza (H1N1) pneumonia during the “herald wave” of the pandemic. Heart Lung. 2010;39:242–8.

    Article  Google Scholar 

  35. Meyer R, Rappo U, Glickman M, Seo SK, Sepkowitz K, Eagan J, et al. Legionella jordanis in hematopoietic SCT patients radiographically mimicking invasive mold infection. Bone Marrow Transpl. 2011;46:1099–103.

    Article  CAS  Google Scholar 

  36. Gonzalez IA, Martin JM. Legionella pneumophilia serogroup 1 pneumonia recurrence postbone marrow transplantation. Pediatr Infect Dis J. 2007;26:961–3.

    Article  Google Scholar 

  37. Larru B, Gerber JS, Ota KV. Medical treatment failure and complete left pneumonectomy after Legionella pneumophila pneumonia in a bone marrow transplant recipient. Pediatr Infect Dis J. 2012;31:979–81.

    Article  Google Scholar 

  38. Schindel C, Siepmann U, Han S, Ullmann AJ, Mayer E, Fischer T, et al. Persistent Legionella infection in a patient after bone marrow transplantation. J Clin Microbiol. 2000;38:4294–5.

    Article  CAS  Google Scholar 

  39. Sivagnanam S, Podczervinski S, Butler-Wu SM, Hawkins V, Stednick Z, Helbert LA, et al. Legionnaires’ disease in transplant recipients: a 15-year retrospective study in a tertiary referral center. Transpl Infect Dis. 2017;19.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Malgorzata Mikulska.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mikulska, M., Tridello, G., Hoek, J. et al. Legionellosis after hematopoietic stem cell transplantation. Bone Marrow Transplant 56, 2555–2566 (2021). https://doi.org/10.1038/s41409-021-01333-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41409-021-01333-7

Search

Quick links